Selected research
Industry Research
Batilol Tablets Industry Research Report 2026
Market perspective
The global Batilol Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Batilol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Batilol Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Batilol Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Batilol Tablets include Anhui Guozheng Pharmaceutical Co., Ltd., Changzhou Siyao Pharmaceutical Co., Ltd., Guangdong Kangqili Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd., Guangzhou Kanghe Pharmaceutical Co., Ltd., Hainan Yier Pharmaceutical Co., Ltd., Hunan Hengwei Pharmaceutical Co., Ltd., Jiangsu Pengyao Pharmaceutical Co., Ltd. and Jiangsu Yabang Epson Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Batilol Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Batilol Tablets Market by Company
Anhui Guozheng Pharmaceutical Co., Ltd.
Changzhou Siyao Pharmaceutical Co., Ltd.
Guangdong Kangqili Pharmaceutical Co., Ltd.
Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
Guangzhou Kanghe Pharmaceutical Co., Ltd.
Hainan Yier Pharmaceutical Co., Ltd.
Hunan Hengwei Pharmaceutical Co., Ltd.
Jiangsu Pengyao Pharmaceutical Co., Ltd.
Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd.
Chongqing Huasen Pharmaceutical Co., Ltd.
Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
Batilol Tablets Segment by Type
50mg
25mg
20mg
Batilol Tablets Segment by Application
Hospital
Clinic
Other
Batilol Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Batilol Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Batilol Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Batilol Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Batilol Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Batilol Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Batilol Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 25mg
- 20mg
Applications
- Hospital
- Clinic
- Other
Companies covered
- Anhui Guozheng Pharmaceutical Co., Ltd.
- Changzhou Siyao Pharmaceutical Co., Ltd.
- Guangdong Kangqili Pharmaceutical Co., Ltd.
- Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
- Guangzhou Kanghe Pharmaceutical Co., Ltd.
- Hainan Yier Pharmaceutical Co., Ltd.
- Hunan Hengwei Pharmaceutical Co., Ltd.
- Jiangsu Pengyao Pharmaceutical Co., Ltd.
- Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
- Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
- Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd.
- Chongqing Huasen Pharmaceutical Co., Ltd.
- Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Batilol Tablets Market Size (2021-2032)
- 2.2.2 Global Batilol Tablets Sales (2021-2032)
- 2.2.3 Global Batilol Tablets Market Average Price (2021-2032)
- 2.3 Batilol Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50mg
- 2.3.3 25mg
- 2.3.4 20mg
- 2.4 Batilol Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Batilol Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Batilol Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Batilol Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Batilol Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Batilol Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Batilol Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Batilol Tablets, Product Type & Application
- 3.8 Global Manufacturers of Batilol Tablets, Established Date
- 3.9 Global Batilol Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Anhui Guozheng Pharmaceutical Co., Ltd.
- 4.1.1 Anhui Guozheng Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Anhui Guozheng Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Anhui Guozheng Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Anhui Guozheng Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.1.5 Anhui Guozheng Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Changzhou Siyao Pharmaceutical Co., Ltd.
- 4.2.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Changzhou Siyao Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Changzhou Siyao Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.2.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Guangdong Kangqili Pharmaceutical Co., Ltd.
- 4.3.1 Guangdong Kangqili Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Guangdong Kangqili Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Guangdong Kangqili Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guangdong Kangqili Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.3.5 Guangdong Kangqili Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.
- 4.4.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.4.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Guangzhou Kanghe Pharmaceutical Co., Ltd.
- 4.5.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.5.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Hainan Yier Pharmaceutical Co., Ltd.
- 4.6.1 Hainan Yier Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Hainan Yier Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Hainan Yier Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hainan Yier Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.6.5 Hainan Yier Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Hunan Hengwei Pharmaceutical Co., Ltd.
- 4.7.1 Hunan Hengwei Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Hunan Hengwei Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Hunan Hengwei Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hunan Hengwei Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.7.5 Hunan Hengwei Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Jiangsu Pengyao Pharmaceutical Co., Ltd.
- 4.8.1 Jiangsu Pengyao Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Jiangsu Pengyao Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Jiangsu Pengyao Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiangsu Pengyao Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.8.5 Jiangsu Pengyao Pharmaceutical Co., Ltd. Recent Developments
- 4.9 Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
- 4.9.1 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.9.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
- 4.10.1 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.10.5 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments
- 4.11 Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd.
- 4.11.1 Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. Company Information
- 4.11.2 Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. Business Overview
- 4.11.3 Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.11.5 Shanghai Xinyi Wanxiang Pharmaceutical Co., Ltd. Recent Developments
- 4.12 Chongqing Huasen Pharmaceutical Co., Ltd.
- 4.12.1 Chongqing Huasen Pharmaceutical Co., Ltd. Company Information
- 4.12.2 Chongqing Huasen Pharmaceutical Co., Ltd. Business Overview
- 4.12.3 Chongqing Huasen Pharmaceutical Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chongqing Huasen Pharmaceutical Co., Ltd. Batilol Tablets Product Portfolio
- 4.12.5 Chongqing Huasen Pharmaceutical Co., Ltd. Recent Developments
- 4.13 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
- 4.13.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
- 4.13.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
- 4.13.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Batilol Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Batilol Tablets Product Portfolio
- 4.13.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
5 Global Batilol Tablets Market Scenario by Region
- 5.1 Global Batilol Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Batilol Tablets Sales by Region: 2021-2032
- 5.2.1 Global Batilol Tablets Sales by Region: 2021-2026
- 5.2.2 Global Batilol Tablets Sales by Region: 2027-2032
- 5.3 Global Batilol Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Batilol Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Batilol Tablets Revenue by Region: 2027-2032
- 5.4 North America Batilol Tablets Market Facts & Figures by Country
- 5.4.1 North America Batilol Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Batilol Tablets Sales by Country (2021-2032)
- 5.4.3 North America Batilol Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Batilol Tablets Market Facts & Figures by Country
- 5.5.1 Europe Batilol Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Batilol Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Batilol Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Batilol Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Batilol Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Batilol Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Batilol Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Batilol Tablets Market Facts & Figures by Country
- 5.7.1 South America Batilol Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Batilol Tablets Sales by Country (2021-2032)
- 5.7.3 South America Batilol Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Batilol Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Batilol Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Batilol Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Batilol Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Batilol Tablets Sales by Type (2021-2032)
- 6.1.1 Global Batilol Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Batilol Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Batilol Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Batilol Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Batilol Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Batilol Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Batilol Tablets Sales by Application (2021-2032)
- 7.1.1 Global Batilol Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Batilol Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Batilol Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Batilol Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Batilol Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Batilol Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Batilol Tablets Value Chain Analysis
- 8.1.1 Batilol Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Batilol Tablets Production Mode & Process
- 8.2 Batilol Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Batilol Tablets Distributors
- 8.2.3 Batilol Tablets Customers
9 Global Batilol Tablets Analyzing Market Dynamics
- 9.1 Batilol Tablets Industry Trends
- 9.2 Batilol Tablets Industry Drivers
- 9.3 Batilol Tablets Industry Opportunities and Challenges
- 9.4 Batilol Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst